AngioDynamics, Inc. Revenue
AngioDynamics, Inc. (ANGO) reported Revenue of $320.17 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-14
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-05-31 was $86.61M, a 8.05% increase year-over-year.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-02-28 was $78.42M, a 8.91% increase year-over-year.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-11-30 was $79.43M, a 9.04% increase year-over-year.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-08-31 was $75.71M, a 12.18% increase year-over-year.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2026 was $320.17M, a 9.46% increase from fiscal 2025.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $292.50M, a 3.76% decline from fiscal 2024.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $303.91M, a 10.28% decline from fiscal 2023.
- AngioDynamics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $338.75M, a 7.13% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-05-31 | $86.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $165.03M derived: sum of 2 quarters · filed 2026-07-14 | $244.46M derived: sum of 3 quarters · filed 2026-07-14 | $320.17M 10-K · filed 2026-07-14 |
| 2026-02-28 | $78.42M 10-Q · filed 2026-04-02 | $157.86M derived: sum of 2 quarters · filed 2026-04-02 | $233.57M 10-Q · filed 2026-04-02 | $313.73M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-11-30 | $79.43M 10-Q · filed 2026-01-06 | $155.14M 10-Q · filed 2026-01-06 | $235.30M derived: sum of 3 quarters · filed 2026-07-14 | $307.31M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-08-31 | $75.71M 10-Q · filed 2025-10-02 | $155.87M derived: sum of 2 quarters · filed 2026-07-14 | $227.87M derived: sum of 3 quarters · filed 2026-07-14 | $300.72M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-05-31 | $80.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $152.16M derived: sum of 2 quarters · filed 2026-07-14 | $225.01M derived: sum of 3 quarters · filed 2026-07-14 | $292.50M 10-K · filed 2026-07-14 |
| 2025-02-28 | $72.00M 10-Q · filed 2026-04-02 | $144.85M derived: sum of 2 quarters · filed 2026-04-02 | $212.34M 10-Q · filed 2026-04-02 | $283.32M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-11-30 | $72.84M 10-Q · filed 2026-01-06 | $140.34M 10-Q · filed 2026-01-06 | $211.32M derived: sum of 3 quarters · filed 2026-07-14 | $286.50M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-08-31 | $67.49M 10-Q · filed 2025-10-02 | $138.47M derived: sum of 2 quarters · filed 2026-07-14 | $213.65M derived: sum of 3 quarters · filed 2026-07-14 | $292.73M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-05-31 | $70.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $146.16M derived: sum of 2 quarters · filed 2026-07-14 | $225.24M derived: sum of 3 quarters · filed 2026-07-14 | $303.91M 10-K · filed 2026-07-14 |
| 2024-02-29 | $75.18M 10-Q · filed 2025-04-02 | $154.25M derived: sum of 2 quarters · filed 2025-04-02 | $232.93M 10-Q · filed 2025-04-02 | $324.01M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-11-30 | $79.07M 10-Q · filed 2025-01-08 | $157.75M 10-Q · filed 2025-01-08 | $248.83M derived: sum of 3 quarters · filed 2025-07-18 | $329.54M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-08-31 | $78.68M 10-Q · filed 2024-10-03 | $169.75M derived: sum of 2 quarters · filed 2025-07-18 | $250.47M derived: sum of 3 quarters · filed 2025-07-18 | $335.89M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-05-31 | $91.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $171.79M derived: sum of 2 quarters · filed 2025-07-18 | $257.21M derived: sum of 3 quarters · filed 2025-07-18 | $338.75M 10-K · filed 2025-07-18 |
| 2023-02-28 | $80.71M 10-Q · filed 2024-04-09 | $166.14M derived: sum of 2 quarters · filed 2024-04-09 | $247.68M 10-Q · filed 2024-04-09 | $334.68M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-11-30 | $85.43M 10-Q · filed 2024-01-08 | $166.97M 10-Q · filed 2024-01-08 | $253.96M derived: sum of 3 quarters · filed 2024-07-25 | $327.93M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-08-31 | $81.54M 10-Q · filed 2023-10-05 | $168.53M derived: sum of 2 quarters · filed 2024-07-25 | $242.50M derived: sum of 3 quarters · filed 2024-07-25 | $320.79M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-05-31 | $87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $160.97M derived: sum of 2 quarters · filed 2024-07-25 | $239.25M derived: sum of 3 quarters · filed 2024-07-25 | $316.22M 10-K · filed 2024-07-25 |
| 2022-02-28 | $73.97M 10-Q · filed 2023-03-31 | $152.25M derived: sum of 2 quarters · filed 2023-03-31 | $229.22M 10-Q · filed 2023-03-31 | $306.06M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-11-30 | $78.28M 10-Q · filed 2023-01-06 | $155.25M 10-Q · filed 2023-01-06 | $232.09M derived: sum of 3 quarters · filed 2023-08-03 | $303.27M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-08-31 | $76.97M 10-Q · filed 2022-10-11 | $153.81M derived: sum of 2 quarters · filed 2023-08-03 | $225.00M derived: sum of 3 quarters · filed 2023-08-03 | $297.76M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-05-31 | $76.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | $148.02M derived: sum of 2 quarters · filed 2023-08-03 | $220.79M derived: sum of 3 quarters · filed 2023-08-03 | $291.01M 10-K · filed 2023-08-03 |
| 2021-02-28 | $71.18M 10-Q · filed 2022-04-07 | $143.95M derived: sum of 2 quarters · filed 2022-04-07 | $214.17M 10-Q · filed 2022-04-07 | |
| 2020-11-30 | $72.77M 10-Q · filed 2022-01-07 | $142.99M 10-Q · filed 2022-01-07 | ||
| 2020-08-31 | $70.22M 10-Q · filed 2021-09-30 | |||
| 2020-05-31 | $264.16M 10-K · filed 2022-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |